Journal of Neurodevelopmental Disorders

Papers
(The TQCC of Journal of Neurodevelopmental Disorders is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Early life stress and development: potential mechanisms for adverse outcomes195
Controlling litter effects to enhance rigor and reproducibility with rodent models of neurodevelopmental disorders59
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications48
Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium45
Pre-symptomatic intervention for autism spectrum disorder (ASD): defining a research agenda38
Behavioural and psychological features of PTEN mutations: a systematic review of the literature and meta-analysis of the prevalence of autism spectrum disorder characteristics35
Behavioural and neural markers of tactile sensory processing in infants at elevated likelihood of autism spectrum disorder and/or attention deficit hyperactivity disorder34
Resting state EEG in youth with ASD: age, sex, and relation to phenotype32
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring31
The prevalence and profile of autism in individuals born preterm: a systematic review and meta-analysis30
Translational outcomes relevant to neurodevelopmental disorders following early life exposure of rats to chlorpyrifos29
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder28
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder27
Risk of neurodevelopmental disorders in children born from different ART treatments: a systematic review and meta-analysis26
Neurodevelopmental and psychiatric disorders in females with Turner syndrome: a population-based study25
Feasibility of delivering parent-implemented NDBI interventions in low-resource regions: a pilot randomized controlled study25
Maternal immune response and air pollution exposure during pregnancy: insights from the Early Markers for Autism (EMA) study25
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)24
Characterisation of the clinical phenotype in Phelan-McDermid syndrome21
Utilization of telemedicine to support caregivers of young children with ASD and their Part C service providers: a comparison of intervention outcomes across three models of service delivery21
Capturing cognitive and behavioral variability among individuals with Down syndrome: a latent profile analysis21
Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study21
Telehealth-enabled behavioral treatment for problem behaviors in boys with fragile X syndrome: a randomized controlled trial21
Prediction of autism spectrum disorder diagnosis using nonlinear measures of language-related EEG at 6 and 12 months21
Associations between sensory processing and electrophysiological and neurochemical measures in children with ASD: an EEG-MRS study20
The electroretinogram b-wave amplitude: a differential physiological measure for Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder20
Intellectual abilities, language comprehension, speech, and motor function in children with spinal muscular atrophy type 119
A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance19
Biomarkers for autism spectrum disorder: opportunities for magnetoencephalography (MEG)18
Longitudinal change in restricted and repetitive behaviors from 8-36 months18
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome18
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language 18
Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases17
An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities17
Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders17
mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus17
0.016216993331909